- Arginine Methylation of hnRNPK Inhibits the DDX3-hnRNPK Interaction to Play an Anti-Apoptosis Role in Osteosarcoma Cells
Chiao-Che Chen et al, 2021, International Journal of Molecular Sciences CrossRef - Prostate cancer and therapeutic challenges
Yousef MohammedRabaa Hawsawi et al, 2020, Journal of Biological Research-Thessaloniki CrossRef - Identification of therapeutic targets and prognostic biomarkers from the hnRNP family in invasive breast carcinoma
Jiawei Zhou et al, 2021, Aging CrossRef - Cell‐by‐cell quantification of the androgen receptor in benign and malignant prostate leads to a better understanding of changes linked to cancer initiation and progression
Seta Derderian et al, 2023, The Journal of Pathology: Clinical Research CrossRef - O‐GlcNAc‐induced nuclear translocation of hnRNP‐K is associated with progression and metastasis of cholangiocarcinoma
Chatchai Phoomak et al, 2019, Molecular Oncology CrossRef - A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers
Philipp Y Maximov et al, 2018, Endocrine-Related Cancer CrossRef - Emerging roles of heterogeneous nuclear ribonucleoprotein K (hnRNP K) in cancer progression
Paola Barboro et al, 2014, Cancer Letters CrossRef - Multifocal Signal Modulation Therapy by Celecoxib: A Strategy for Managing Castration-Resistant Prostate Cancer
Roberto Benelli et al, 2019, International Journal of Molecular Sciences CrossRef - RNA-binding motif protein RBM47 promotes tumorigenesis in nasopharyngeal carcinoma through multiple pathways
Xiao-Chen Xu et al, 2021, Journal of Genetics and Genomics CrossRef - The ErbB family and androgen receptor signaling are targets of Celecoxib in prostate cancer
Antonella Brizzolara et al, 2017, Cancer Letters CrossRef - Prognostic relevance of androgen receptor expression in renal cell carcinomas
Sebastian Foersch et al, 2017, Oncotarget CrossRef - HnRNPM is a potential mediator of YY1 which promotes EMT in prostate cancer cells
Tong Yang et al, 2019, The Prostate CrossRef - Knockdown of hnRNPK leads to increased DNA damage after irradiation and reduces survival of tumor cells
Nadine Wiesmann et al, 2017, Carcinogenesis CrossRef - Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer
Nicoletta Ferrari et al, 2017, Cell Communication and Signaling CrossRef - The emerging roles of hnRNPK
Ziyi Wang et al, 2020, Journal of Cellular Physiology CrossRef - Caveolin‐1‐driven membrane remodelling regulates hnRNPK‐mediated exosomal microRNA sorting in cancer
Harley Robinson et al, 2021, Clinical and Translational Medicine CrossRef - Gene’s expression underpinning the divergent predictive value of [18F]F-fluorodeoxyglucose and prostate-specific membrane antigen positron emission tomography in primary prostate cancer: a bioinformatic and experimental study
Matteo Bauckneht et al, 2023, Journal of Translational Medicine CrossRef - Stromal Androgen Receptor in Prostate Cancer Development and Progression
Damien Leach et al, 2017, Cancers CrossRef - Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer
Ruirui Yang et al, 2016, Oncology Reports CrossRef - Expression of nuclear matrix proteins binding matrix attachment regions in prostate cancer. PARP‐1: New player in tumor progression
Paola Barboro et al, 2015, International Journal of Cancer CrossRef - A hnRNP K–AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer
Matteo Capaia et al, 2018, International Journal of Molecular Sciences CrossRef - Role of heterogeneous nuclear ribonucleoprotein K in tumor development
Yuting Chen et al, 2019, Journal of Cellular Biochemistry CrossRef